John P. Fruehauf
- Molecular Biology top 5%
- Oncology top 2%
- Cancer Research top 2%
- Pulmonary and Respiratory Medicine top 5%
- Reproductive Medicine top 2%
- Co-authors
- Frank L. MeyskensAinura KyshtoobayevaR. J. ParkerPatrick J. FarmerEugene MechetnerRita S. MehtaRobert A. BurgerHak Joong Kim
- Topics
- Ovarian cancer diagnosis and treatment (16 papers)Angiogenesis and VEGF in Cancer (13 papers)Melanoma and MAPK Pathways (11 papers)
- Journals
- Journal of Clinical OncologyMolecular and Cellular BiologyJNCI Journal of the National Cancer Institute
- Partner nations
- United StatesItalyAustria
In The Last Decade
John P. Fruehauf
98 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 134
- Molecular Biology 2.1k
- Oncology 1.4k
- Cancer Research 756
- Pulmonary and Respiratory Medicine 567
- Reproductive Medicine 371
Countries citing papers authored by John P. Fruehauf
This map shows the geographic impact of John P. Fruehauf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. Fruehauf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. Fruehauf more than expected).
Fields of papers citing papers by John P. Fruehauf
This network shows the impact of papers produced by John P. Fruehauf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. Fruehauf. The network helps show where John P. Fruehauf may publish in the future.
Co-authorship network of co-authors of John P. Fruehauf
This figure shows the co-authorship network connecting the top 25 collaborators of John P. Fruehauf. A scholar is included among the top collaborators of John P. Fruehauf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John P. Fruehauf. John P. Fruehauf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 32 | |
| 3 | 0 | |
| 4 | 13 | |
| 5 | 93 | |
| 6 | 148 | |
| 7 | 106 | |
| 8 | 19 | |
| 9 | 40 | |
| 10 | Synergistic interactions of disulfiram, BSO and arsenic trioxide on drug resistant melanoma cell lines. | 1 |
| 11 | 44 | |
| 12 | 6 | |
| 13 | 179 | |
| 14 | 72 | |
| 15 | The UIC2 shift assay detects functional P-glycoprotein in tumors and correlates with in vitro drug response to doxorubicin | 1 |
| 16 | 65 | |
| 17 | 26 | |
| 18 | 18 | |
| 19 | 9 | |
| 20 | 28 |
About John P. Fruehauf
John P. Fruehauf is a scholar working on Reproductive Medicine, Oncology and Obstetrics and Gynecology, having authored 100 papers that have together received 4.2k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (16 papers), Angiogenesis and VEGF in Cancer (13 papers) and Melanoma and MAPK Pathways (11 papers). The work is most often cited by research in Oncology (1.4k citations), Cancer Research (756 citations) and Reproductive Medicine (371 citations). John P. Fruehauf has collaborated with scholars based in United States, Italy and Austria. Frequent co-authors include Frank L. Meyskens, Ainura Kyshtoobayeva, R. J. Parker, Patrick J. Farmer, Eugene Mechetner, Rita S. Mehta, Robert A. Burger, Hak Joong Kim, Robert Stroup and Christine E. McLaren. Their work appears in journals such as Journal of Clinical Oncology, Molecular and Cellular Biology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.